The Numbers

Theradaptive OsteoAdapt in Cage

Theradaptive Awarded DOD Clinical Trial Award

This award will help Theradaptive scale up the production of its OsteoAdapt regenerative therapeutic product for spine and trauma repair.

The largest companies in the spine market are increasingly focused on digital technologies to drive market share gains.

Globus Driving Share Wins on Strength of Technology

The largest companies in the spine market are increasingly focused on digital technologies to drive market share gains.

Sparta's Ormi device received FDA's Breakthrough Device Designation in 2021 to treat knee osteoarthritis.

Sparta Biomedical Raises Funds for Knee OA Treatment

Sparta’s Ormi device received FDA’s Breakthrough Device Designation in 2021 to treat knee osteoarthritis.

Theradaptive Awarded DOD Clinical Trial Award

This award will help Theradaptive scale up the production of its OsteoAdapt regenerative therapeutic product for spine and trauma repair.

,
Globus Driving Share Wins on Strength of Technology

The largest companies in the spine market are increasingly focused on digital technologies to drive market share gains.

,
Sparta Biomedical Raises Funds for Knee OA Treatment

Sparta’s Ormi device received FDA’s Breakthrough Device Designation in 2021 to treat knee osteoarthritis.

,
AK Medical Sees Rapid Growth in Wake of VBP

The company grew more than 20% in the first half of 2023 primarily as a result of volume won during China’s volume-based procurement tenders.

,
MicroPort Orthopedics Overcomes Supply Challenges in First Half of 2023

The company grew in the high single digits in the first half of 2023 as it overcome supply challenges domestically and internationally.

,
Medtronic Off to Fast Start in New Fiscal Year

The company grew in the high-single-digits in FY1Q24 driven by sales and pull-through from its Aible digital ecosystem.

,
Medartis on Track for Growth Targets After First Half

The company grew in the mid-teens for the first half of 2023, driven by strength across its trauma portfolio and geographic regions.

,
Shoulder Innovations Secures $45 Million Debt Facility

This additional capital will bolster efforts to rapidly expand both commercial and technology initiatives for the company.

,
Orthopedic Market Likely in Extended Rebound

Surgical volumes are healthy while staffing and supply are improving slowly. Industry leaders expect volume tailwinds into 2024.

,
Bioventus Stabilizes, Assesses Path Forward

In the second quarter of 2023, the company took steps to stabilize its financial position and assess its strategic path forward.

,
Anika Therapeutics Sees Early Returns on Recent Launches

The company’s orthopedic sales grew in the mid-teens for the second quarter of 2023 on the strength of favorable order timing.

,
Vericel’s Expanding Surgeon Base Drives MACI Growth

The company’s MACI sales grew 27% in the second quarter of 2023 while both surgeon and biopsy trends point to sustained momentum.

,
SI-BONE’s Robust Demand Leads to Record Quarter

The company notched its fifth consecutive quarter of record revenues in 2Q23, with growth over 30% due to increased demand and new products.

,
Treace Medical’s Specialization Leads to Rapid Growth

The company grew 40% in the second quarter of 2023 due to its sole focus on bunion surgery and its specialized sales force.

,
Enovis Bullish on Second Half Despite Tougher Comps

The company grew in the mid-teens for the second quarter of 2023 and raised full-year guidance despite tougher comps in the second half.

,

Contact Us

0